Results 111 to 120 of about 7,072 (218)

Proteomic pathways across the ejection fraction spectrum in patients with heart failure and diabetes mellitus: an EXSCEL trial substudy [PDF]

Ejection fraction (EF) is a key component of heart failure (HF) classification. However, the biologic basis of HF with mildly reduced EF (HFmrEF) as a distinct biologic entity distinct from HF with preserved EF (HFpEF) and reduced EF (HFrEF) has not been
Buse, John B., Green, Jennifer B., Hernandez, Adrian F., Holman, Rury R., Mentz, Robert J., Nguyen, Maggie, Pearson, Ewan R, Peters, Anthony E., Sattar, Naveed, Shah, Svati H., Sourij, Harald   +10 more
core   +2 more sources

Contemporary Use and Implications of Beta-Blockers in Patients With HFmrEF or HFpEF: The DELIVER Trial.

JACC. Heart failure, 2023
Although beta-blockers are not recommended for the treatment of heart failure with preserved ejection fraction (HFpEF) according to the latest European Society of Cardiology and American Heart Association/American College of Cardiology/Heart Failure Society of America guidelines, these therapies remain commonly used for comorbidity management.
Peikert, Alexander, Bart, Bradley A., Vaduganathan, Muthiah, Claggett, Brian L., Kulac, Ian J., Kosiborod, Mikhail N., Desai, Akshay S., Jhund, Pardeep S., Lam, Carolyn S.P., Inzucchi, Silvio E., Martinez, Felipe A., de Boer, Rudolf A., Hernandez, Adrian F., Shah, Sanjiv J., Petersson, Magnus, Langkilde, Anna Maria, McMurray, John J.V., Solomon, Scott D., Vardeny, Orly   +18 more
openaire   +3 more sources

LV Strain Superiority Over LVEF in HFmrEF

JACC: Advances, 2023
Giuseppe Galati, Olga Germanova, Roberto Franco Enrico Pedretti   +2 more
openaire   +1 more source

HFmrEF: Közepes ejekciós frakciójú szívelégtelenség [PDF]

Cardiologia Hungarica, 2019
openaire   +2 more sources

Iron deficiency in patients with heart failure with mid-range and preserved ejection fraction [PDF]

, 2019
Trabalho Final do Curso de Mestrado Integrado em Medicina, Faculdade de Medicina, Universidade de Lisboa, 2019Introdução: O ferro é essencial para a produção de bioenergia, eficácia do sistema imunitário e desenvolvimento do sistema nervoso central.
Morgado, Diogo Jácome
core  

Sex differences in mortality and hospitalization in heart failure with preserved and mid-range ejection fraction: a systematic review and meta-analysis of cohort studies

Frontiers in Cardiovascular Medicine
IntroductionThe influence of sex on the prognosis of heart failure with preserved or intermediate ejection fraction (HFpEF and HFmrEF) remains uncertain.
You Deng, Jun Zhang, Jitao Ling, Qingwen Hu, Tianggang Song, Yi Xu, Menglu Liu, Yuting Wu, Kaibo Mei, Jiawei Chen, Huilei Zhao, Xiao Liu   +11 more
doaj   +1 more source

Electrocardiography-based artificial intelligence predicts the upcoming future of heart failure with mildly reduced ejection fraction

Frontiers in Cardiovascular Medicine
BackgroundHeart failure with mildly reduced ejection fraction (HFmrEF) has emerged as the predominant subtype of heart failure (HF). This study aimed to develop artificial intelligence (AI)-electrocardiography (ECG) to identify and predict the prognosis ...
Dae-Young Kim, Sang-Won Lee, Dong-Ho Lee, Sang-Chul Lee, Sang-Chul Lee, Ji-Hun Jang, Sung-Hee Shin, Dae-Hyeok Kim, Dae-Hyeok Kim, Wonik Choi, Wonik Choi, Yong-Soo Baek, Yong-Soo Baek, Yong-Soo Baek   +13 more
doaj   +1 more source

Finerenone: A breakthrough drug for patients of HFmrEF and HFpEF

Journal of the Pakistan Medical Association
Madam, Heart failure (HF) is one of the major cardiovascular diseases, affecting more than 64 million people worldwide.1 HFmrEF and HFpEF are subtypes of HF characterised by LVEFs of 41-49% and >50%, respectively.1 ARBs, ACE inhibitors, aldosterone antagonists and loop diuretics are some of the drug classes that have been used in the management of ...
openaire   +1 more source

P6197Patients with HFrEF, HFmrEF and HFpEF, are they so different? [PDF]

European Heart Journal, 2017
E. Goncalvesova, P. Lesny, M. Luknar, M. Dankova, V. Simovicova, M. Kovacova   +5 more
openaire   +1 more source

Coronary Chronic Total Occlusions Affect Long‐Term Prognosis in Heart Failure With Mildly Reduced Ejection Fraction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background This study investigates the prevalence and prognostic impact of coronary chronic total occlusions (CTO) in patients with heart failure with mildly reduced ejection fraction (HFmrEF).
Michael Behnes, Moritz Schmidberger, Kambis Mashayekhi, Giuseppe Vadalà, Alice Moroni, Juan‐Luis Guiterrez‐Chico, Mohamed Ayoub, Evald Høj Christiansen, Stylianos Pyxaras, Alexander Bufe, Florian Krötz, Alexander Schmitt, Felix Lau, Marielen Reinhardt, Jan Forner, Jonas Dudda, Noah Abel, Mila Kathrin Hoepfner, Cedric Aubel, Mohammad Abumayyaleh, Kathrin Weidner, Ibrahim Akin, Tobias Schupp   +22 more
doaj   +1 more source